Perlara in the news
November 1, 2017
Perlara Announces $7.4M Equity Financing
January 31, 2017
Perlara Announces Third Patient Advocacy Group Partnership
January 10, 2017
Perlara PBC Announces Patient Advocacy Group Partnerships
July 31, 2014
Perlstein Lab Seed Round
The latest from our Blog
This is my first post in a few months, and a lot has changed at Perlara since then! We doubled in size, expanding and creating more research teams, and launched multiple PerlQuests in addition to the original PerlQuest for NGLY1 deficiency. Our latest news is that...
In 2016, Perlara and Grace Science Foundation launched a PerlQuest for NGLY1 Deficiency (also known as NGLY1-CDDG). As a part of this collaboration, we have embarked on developing an NGLY1 worm screen. This post will detail the worm team's latest progress toward...
On March 1, 2018, Perlara PBC and Global Genes hosted an event in honor of World Rare Disease Day. The first of two fireside chats featured four Bay Area biotech CEOs working on rare diseases, who shared their stories of how they came to ‘care about rare’. This was...